Cognition and Cancer Conference International Cognition and Cancer Task Force
March 8, 2010 and March 9, 2010
Type:
CME
Summary:
The goal of this conference is to present and discuss current research examining the impact of cancer and cancer-related treatment on cognitive and behavioral functioning in adults with non-central nervous system cancers. Presentations will focus on state-of-the-art research elucidating the nature of the cognitive and neurobehavioral sequelae associated with cancer and cancer therapies, the mechanisms that underlie these changes in function, and interventions to prevent or manage these undesired symptoms and/or their side effects.
Overview of the Clinical and Research Aspects of Cognition and Cancer
Patricia Ganz, MD Professor of Health Services and Medicine Department of Health Services Director, Division of Cancer Prevention and Control Research Jonsson Comprehensive Cancer Center University of California, Los Angeles
Jeffrey S. Wefel, PhD Assistant Professor Section of Neuropsychology Department of Neuro-Oncology University of Texas M.D. Anderson Cancer Center
Use of Imaging to Study Cognitive Changes Associated with Cancer and Cancer Treatments
Andrew J. Saykin, PsyD, ABCN Raymond C. Beeler Professor of Radiology Director, Center for Neuroimaging Indiana University School of Medicine
Age Related Cognitive Decline
Monique M.B. Breteler, MD, PhD Professor of Neuroepidemiology, Erasmus University, Rotterdam Professor of Epidemiology (adjunct), Harvard University, Boston
Pharmacogenetic Factors Associated with Cancer Therapy Related Cognitive Dysfunction
M. Fatih Okcu, MD, MPH Associate Professor Department of Pediatrics (Hematology-Oncology) Baylor College of Medicine
Animal Studies Examining Mechanisms of Cognitive Changes Associated with Cancer Treatments
Mark D. Noble, PhD Professor, Department of Biomedical Genetics Director, Stem Cell and Regenerative Medicine Institute University of Rochester
Audience:
This conference is directed toward researchers and clinicians interested in state-of-the-art information related to the most current and ongoing research examining issues of cognition and cancer.
Credit:
Memorial Sloan-Kettering Cancer Center designates this educational activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Location:
Memorial Sloan-Kettering Cancer Center
Rockefeller Research Laboratories
Auditorium
430 East 67th Street
Between First and York Avenues
New York, NY 10065
Accommodations:
Memorial Sloan-Kettering is pleased to offer discounted hotel rates near to the hospital.
The deadline for abstracts is November 15, 2009. Abstracts should not exceed 300 words. An abstract should include the following sections:
Authors, Institutional Affiliations, e-mail of the corresponding author, Purpose, Methods, Results, and Conclusions.
Abstracts will be selected for a poster presentation by the conference committee on the basis of their scientific merit and content quality. A small number of abstracts will be selected for oral presentation. Preference will be given to abstracts describing study results.
Abstracts may be submitted via e-mail to Fred Johnson at johnsonf@mskcc.org. Please insert ICCTF Abstract in the Subject Heading.
Course Design
This course is comprised of lectures and interactive audience participation encouraging the intellectual exchange of ideas between faculty and participants.
Evaluation
A course evaluation form will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.
Registration Information
You will be given the opportunity to pay online or by mail.
Early Bird (before 02/01/10)
$250.00
General Admission
$150.00
Fellows, Residents, and Other Healthcare Professionals
General Fee (02/02/10 to 03/08/10)
$300.00
General Admission
$150.00
Fellows, Residents, and Other Healthcare Professionals
